PRESS RELEASE published on 02/11/2026 at 17:45, 2 months 25 days ago Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital Disclosure of total voting rights and shares as of Jan 31, 2026 by Median Technologies. Cutting-edge AI for cancer diagnoses and treatments. Listed on Euronext Growth market Voting Rights Shares AI Median Technologies Cancer Diagnoses
PRESS RELEASE published on 02/11/2026 at 17:00, 2 months 25 days ago Mutares has completed the acquisition of Venator Ultramarine Blue Pigments business from Venator France SAS Mutares completes acquisition of Venator Ultramarine Blue Pigments business from Venator France SAS, strengthening Chemicals & Materials segment with strategic move into specialty chemicals industry Acquisition Specialty Chemicals Mutares Venator Chemicals & Materials
PRESS RELEASE published on 02/11/2026 at 16:40, 2 months 25 days ago Guidepoint Launches Guidepoint360 Mobile App, Delivering AI-Driven Research Whenever It's Needed Guidepoint launches Guidepoint360 mobile app, providing AI-driven research on-the-go. The app offers real-time expert intelligence for institutional investors, consulting firms, and enterprises, facilitating high-stakes decisions under tight timelines Mobile App AI-driven Research Guidepoint Guidepoint360 Expert Intelligence
PRESS RELEASE published on 02/11/2026 at 16:00, 2 months 25 days ago Eleving Group: the recording of 12M 2025 earnings call Eleving Group organized the 12M 2025 earnings call, presenting unaudited financial results and achievements, available for viewing. The company operates in 17 countries, offering financial services Financial Results Technology Earnings Call Eleving Group International Finance
PRESS RELEASE published on 02/11/2026 at 15:04, 2 months 25 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.08% stake in JTC plc through 8,756,673 shares with a position date of 10 February 2026 The Vanguard Group Stake Disclosure 5.08% JTC Plc 8,756,673 Shares
PRESS RELEASE published on 02/11/2026 at 15:03, 2 months 25 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses 5.54% stake in Avadel Pharmaceuticals plc as of 10 Feb 2026. Form 8.3 filed with the Irish Takeover Panel Form 8.3 Irish Takeover Panel The Vanguard Group Stake Disclosure Avadel Pharmaceuticals Plc
PRESS RELEASE published on 02/11/2026 at 15:02, 2 months 25 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses 5.03% ownership in Beazley plc as of 10-Feb-2026 Relevant Securities The Vanguard Group Ownership Disclosure Financial Disclosure Beazley Plc
PRESS RELEASE published on 02/11/2026 at 14:59, 2 months 25 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses 3.60% stake in Spire Healthcare Group plc. Public disclosure under Rule 8.3 of the Takeover Code on 11 Feb 2026 Rule 8.3 Vanguard Group Inc. Takeover Code Stake Disclosure Spire Healthcare Group Plc
PRESS RELEASE published on 02/11/2026 at 14:58, 2 months 25 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses 4.93% ownership in Just Group plc in a Form 8.3 filing. Public position disclosure under Rule 8.3 of the Takeover Code Form 8.3 Takeover Code Vanguard Group Ownership Disclosure Just Group Plc
PRESS RELEASE published on 02/11/2026 at 14:57, 2 months 25 days ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited The Vanguard Group, Inc. files Form 8.3 for Picton Property Income Limited disclosing 5.25% ownership of relevant securities. No other party disclosures made Securities Form 8.3 Vanguard Group Ownership Disclosure Picton Property Income Limited
Published on 05/09/2026 at 01:30, 42 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 2 hours 12 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 5 hours 34 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 6 hours 59 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 7 hours 10 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 6 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:06, 1 day 7 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 18:17, 1 day 7 hours ago DESCRIPTION OF THE LOUIS HACHETTE GROUP SHARE BUYBACK PROGRAM 2026-2027
Published on 05/07/2026 at 17:45, 1 day 8 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL